Article Details

Ocular Therapeutix (NASDAQ:OCUL) Rating Lowered to Sell at ValuEngine

Retrieved on: 2019-05-09 06:18:45

Tags for this article:

Click the tags to see associated articles and topics

Ocular Therapeutix (NASDAQ:OCUL) Rating Lowered to Sell at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Man Group plc</b> purchased a new stake in shares of Ocular Therapeutix during the third quarter worth $3,461,000. BlackRock Inc. grew its holdings in ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up